• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有家族性乳腺癌和卵巢癌风险的女性对乳腺癌监测项目的依从性与过度筛查:德国一项单中心研究

Adherence to the breast cancer surveillance program for women at risk for familial breast and ovarian cancer versus overscreening: a monocenter study in Germany.

作者信息

Vetter Lisa, Keller Monika, Bruckner Thomas, Golatta Michael, Eismann Sabine, Evers Christina, Dikow Nicola, Sohn Christof, Heil Jörg, Schott Sarah

机构信息

Department of Obstetrics and Gynecology, University Hospital Heidelberg, Im Neuenheimer Feld 440, 69120, Heidelberg, Germany.

Department of Psychosomatic, Internal Medicine, University Hospital Heidelberg, Heidelberg, Germany.

出版信息

Breast Cancer Res Treat. 2016 Apr;156(2):289-99. doi: 10.1007/s10549-016-3748-5. Epub 2016 Mar 9.

DOI:10.1007/s10549-016-3748-5
PMID:26960712
Abstract

Breast cancer (BC) is the leading cancer among women worldwide and in 5-10 % of cases is of hereditary origin, mainly due to BRCA1/2 mutations. Therefore, the German Consortium for Familial Breast and Ovarian Cancer (HBOC) with its 15 specialized academic centers offers families at high risk for familial/hereditary cancer a multimodal breast cancer surveillance program (MBCS) with regular breast MRI, mammography, ultrasound, and palpation. So far, we know a lot about the psychological effects of genetic testing, but we know little about risk-correlated adherence to MBCS or prophylactic surgery over time. The aim of this study was to investigate counselees' adherence to recommendations for MBCS in order to adjust the care supply and define predictors for incompliance. All counselees, who attended HBOC consultation at the University Hospital Heidelberg between July 01, 2009 and July 01, 2011 were eligible to participate. A tripartite questionnaire containing sociodemographic information, psychological parameters, behavioral questions, and medical data collection from the German consortium were used. A high participation rate was achieved among the study population, with 72 % returning the questionnaire. This study showed a rate of 59 % of full-adherers to the MBCS. Significant predictors for partial or full adherence were having children (p = 0.0221), younger daughters (p = 0.01795), a higher awareness of the topic HBOC (p = 0.01795, p < 0.0001), a higher perceived breast cancer risk (p < 0.0001), and worries (p = 0.0008)/impairment (p = 0.0257) by it. Although the current data suggest a good adherence of MBCS, prospective studies are needed to understand counselees' needs to further improve surveillance programs and adherence to them. Adherence to the breast cancer surveillance program for women at risk for familial breast and ovarian cancer versus overscreening-a monocenter study in Germany.

摘要

乳腺癌(BC)是全球女性中最常见的癌症,5%-10%的病例为遗传性,主要归因于BRCA1/2基因突变。因此,由15个专业学术中心组成的德国家族性乳腺癌和卵巢癌联盟(HBOC)为有家族性/遗传性癌症高风险的家庭提供了一项多模式乳腺癌监测计划(MBCS),包括定期进行乳腺磁共振成像(MRI)、乳房X线摄影、超声检查和触诊。到目前为止,我们对基因检测的心理影响了解很多,但对于随着时间推移与风险相关的MBCS或预防性手术的依从性了解甚少。本研究的目的是调查咨询对象对MBCS建议的依从性,以便调整护理服务并确定不依从的预测因素。所有在2009年7月1日至2011年7月1日期间到海德堡大学医院参加HBOC咨询的咨询对象均有资格参与。使用了一份包含社会人口统计学信息、心理参数、行为问题以及来自德国联盟的医疗数据收集的三方问卷。研究人群的参与率很高,72%的人返回了问卷。本研究显示,完全遵守MBCS的比例为59%。部分或完全依从的显著预测因素包括有子女(p = 0.0221)、较年轻的女儿(p = 0.01795)、对HBOC主题的更高认知度(p = 0.01795,p < 0.0001)、更高的感知乳腺癌风险(p < 0.0001)以及由此产生的担忧(p = 0.0008)/损害(p = 0.0257)。尽管目前的数据表明MBCS的依从性良好,但仍需要前瞻性研究来了解咨询对象的需求,以进一步改进监测计划及其依从性。家族性乳腺癌和卵巢癌风险女性对乳腺癌监测计划的依从性与过度筛查——德国的一项单中心研究

相似文献

1
Adherence to the breast cancer surveillance program for women at risk for familial breast and ovarian cancer versus overscreening: a monocenter study in Germany.有家族性乳腺癌和卵巢癌风险的女性对乳腺癌监测项目的依从性与过度筛查:德国一项单中心研究
Breast Cancer Res Treat. 2016 Apr;156(2):289-99. doi: 10.1007/s10549-016-3748-5. Epub 2016 Mar 9.
2
[Risk-adapted surveillance: focus on familial breast and ovarian cancer].[风险适应性监测:聚焦家族性乳腺癌和卵巢癌]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Mar;57(3):307-11. doi: 10.1007/s00103-013-1910-3.
3
Implementing a screening tool for identifying patients at risk for hereditary breast and ovarian cancer: a statewide initiative.实施一种用于识别遗传性乳腺癌和卵巢癌高危患者的筛查工具:一项全州范围的倡议。
Ann Surg Oncol. 2014 Oct;21(10):3342-7. doi: 10.1245/s10434-014-3921-1. Epub 2014 Jul 22.
4
Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.接受BRCA1和BRCA2检测的女性临床特征与风险降低干预措施之间的关联:一项单机构研究。
Cancer. 2006 Dec 15;107(12):2745-51. doi: 10.1002/cncr.22352.
5
Exploring the short-term impact of DNA-testing in breast cancer patients: the counselees' perception matters, but the actual BRCA1/2 result does not.探讨 DNA 检测在乳腺癌患者中的短期影响:咨询者的看法很重要,但实际的 BRCA1/2 结果并不重要。
Patient Educ Couns. 2012 Feb;86(2):239-51. doi: 10.1016/j.pec.2011.04.017. Epub 2011 Dec 27.
6
[Clinical and molecular diagnosis of inherited breast-ovarian cancer].遗传性乳腺癌-卵巢癌的临床与分子诊断
J Gynecol Obstet Biol Reprod (Paris). 2003 Apr;32(2):101-19.
7
Women at familial risk of breast cancer electing for prophylactic mastectomy: frequencies, procedures, and decision-making characteristics.有家族性乳腺癌风险的女性选择预防性乳房切除术:频率、手术方式及决策特征
Arch Gynecol Obstet. 2017 Jun;295(6):1451-1458. doi: 10.1007/s00404-017-4376-y. Epub 2017 Apr 24.
8
Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.携带BRCA1和BRCA2突变的阿什肯纳兹犹太女性患卵巢癌的风险。
Clin Cancer Res. 2002 Dec;8(12):3776-81.
9
Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.被诊断患有两种原发性癌症的女性中的遗传性癌症相关突变:在首次癌症诊断后识别遗传性癌症综合征的契机。
Oncology. 2015;88(4):226-33. doi: 10.1159/000368836. Epub 2014 Dec 11.
10
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.

引用本文的文献

1
Measurement properties of the Iranian version of the breast cancer perception scale (BCPS) according to the COSMIN checklist.根据 COSMIN 清单评估伊朗版乳腺癌感知量表 (BCPS) 的测量特性。
BMC Cancer. 2024 Jun 18;24(1):743. doi: 10.1186/s12885-024-12493-2.
2
Specialty Care and Counselling about Hereditary Cancer Risk Improves Adherence to Cancer Screening and Prevention in Newfoundland and Labrador Patients with Pathogenic Variants: A Population-Based Retrospective Cohort Study.特殊护理和遗传性癌症风险咨询可提高纽芬兰和拉布拉多携带致病性变异患者的癌症筛查和预防依从性:基于人群的回顾性队列研究。
Curr Oncol. 2023 Oct 22;30(10):9367-9381. doi: 10.3390/curroncol30100678.
3
Longitudinal adherence to breast cancer surveillance following cancer genetic testing in an integrated health care system.
在综合医疗体系中进行癌症基因检测后,对乳腺癌监测的长期依从性。
Breast Cancer Res Treat. 2023 Oct;201(3):461-470. doi: 10.1007/s10549-023-07007-w. Epub 2023 Jul 20.
4
Predictors of nonadherence to breast cancer screening guidelines in a United States urban comprehensive cancer center.美国城市综合癌症中心中乳腺癌筛查指南不依从的预测因素。
Cancer Med. 2023 Jul;12(14):15482-15491. doi: 10.1002/cam4.6182. Epub 2023 Jun 17.
5
Relationship of attitudes toward uncertainty and preventive health behaviors with breast cancer screening participation.对不确定性的态度和预防保健行为与乳腺癌筛查参与的关系。
BMC Womens Health. 2021 Apr 21;21(1):171. doi: 10.1186/s12905-021-01317-1.
6
NF1 Patients Receiving Breast Cancer Screening: Insights from The Ontario High Risk Breast Screening Program.接受乳腺癌筛查的1型神经纤维瘤病患者:来自安大略省高危乳腺癌筛查项目的见解
Cancers (Basel). 2019 May 22;11(5):707. doi: 10.3390/cancers11050707.
7
Is risk-stratified breast cancer screening economically efficient in Germany?在德国,基于风险分层的乳腺癌筛查具有经济效益吗?
PLoS One. 2019 May 23;14(5):e0217213. doi: 10.1371/journal.pone.0217213. eCollection 2019.
8
Risk perception and screening behavior of Filipino women at risk for breast cancer: implications for cancer genetic counseling.菲律宾乳腺癌高危女性的风险认知与筛查行为:对癌症遗传咨询的启示
J Community Genet. 2019 Apr;10(2):281-289. doi: 10.1007/s12687-018-0391-3. Epub 2018 Sep 27.
9
Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in Mutation Carriers.双侧增强磁共振动态对比成像对携带突变的乳腺癌进行强化监测。
Clin Cancer Res. 2019 Mar 15;25(6):1786-1794. doi: 10.1158/1078-0432.CCR-18-0200. Epub 2018 Aug 28.
10
Familial breast cancer: Genetic counseling over time, including patients´ expectations and initiators considering the Angelina Jolie effect.家族性乳腺癌:长期的遗传咨询,包括患者的期望以及考虑到安吉丽娜·朱莉效应的引发因素。
PLoS One. 2017 May 25;12(5):e0177893. doi: 10.1371/journal.pone.0177893. eCollection 2017.